Bartz-Schmidt KU - Search Results

1

Hypothermia Protects and Prolongs the Tolerance Time of Retinal Ganglion Cells against Ischemia.

Schultheiss M, Schnichels S, Hermann T, Hurst J, Feldkaemper M, Arango-Gonzalez B, Ueffing M, Bartz-Schmidt KU, Zeck G, Spitzer MS. Schultheiss M, et al. PLoS One. 2016 Feb 5;11(2):e0148616. doi: 10.1371/journal.pone.0148616. eCollection 2016. PLoS One. 2016. PMID: 26848953 Free PMC article.

2

Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells.

Szurman P, Kaczmarek R, Spitzer MS, Jaissle GB, Decker P, Grisanti S, Henke-Fahle S, Aisenbrey S, Bartz-Schmidt KU. Szurman P, et al. Exp Eye Res. 2006 Sep;83(3):584-92. doi: 10.1016/j.exer.2006.02.012. Epub 2006 May 8. Exp Eye Res. 2006. PMID: 16684520

3

Influence of different purification techniques on triamcinolone yield and particle size spectrum.

Szurman P, Kaczmarek R, Jaissle GB, Grisanti S, Lüke M, Spitzer MS, Heide PE, Bartz-Schmidt KU. Szurman P, et al. Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):689-96. doi: 10.1007/s00417-006-0436-x. Epub 2006 Sep 28. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17006679

4

Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells.

Spitzer MS, Yoeruek E, Sierra A, Wallenfels-Thilo B, Schraermeyer U, Spitzer B, Bartz-Schmidt KU, Szurman P. Spitzer MS, et al. Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1837-42. doi: 10.1007/s00417-007-0568-7. Epub 2007 Mar 9. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17347807

5

Primary silicone oil tamponade in the management of severe intraocular foreign body injuries: an 8-year follow-up.

Szurman P, Roters S, Grisanti S, Aisenbrey S, Rohrbach JM, Warga M, Gelisken F, Spitzer MS, Bartz-Schmidt KU. Szurman P, et al. Retina. 2007 Mar;27(3):304-11. doi: 10.1097/01.iae.0000237685.99713.83. Retina. 2007. PMID: 17460585

6

Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo.

Szurman P, Sierra A, Kaczmarek R, Jaissle GB, Wallenfels-Thilo B, Grisanti S, Lüke M, Bartz-Schmidt KU, Spitzer MS. Szurman P, et al. Exp Eye Res. 2007 Jul;85(1):44-53. doi: 10.1016/j.exer.2007.03.003. Epub 2007 Mar 19. Exp Eye Res. 2007. PMID: 17475249

7

Safety profile of bevacizumab on cultured human corneal cells.

Yoeruek E, Spitzer MS, Tatar O, Aisenbrey S, Bartz-Schmidt KU, Szurman P. Yoeruek E, et al. Cornea. 2007 Sep;26(8):977-82. doi: 10.1097/ICO.0b013e3180de1d0a. Cornea. 2007. PMID: 17721300

8

Toxic effects of recombinant tissue plasminogen activator on cultured human corneal endothelial cells.

Yoeruek E, Spitzer MS, Tatar O, Biedermann T, Grisanti S, Lüke M, Bartz-Schmidt KU, Szurman P. Yoeruek E, et al. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1392-7. doi: 10.1167/iovs.07-1079. Invest Ophthalmol Vis Sci. 2008. PMID: 18385055

9

Intravitreal bevacizumab in postoperative pseudophakic cystoid macular edema: does it really work?

Spitzer MS, Szurman P, Bartz-Schmidt KU. Spitzer MS, et al. J Cataract Refract Surg. 2008 Jun;34(6):880; author reply 880-1. doi: 10.1016/j.jcrs.2008.02.030. J Cataract Refract Surg. 2008. PMID: 18498977 No abstract available.

10

Ocular surface squamous neoplasia as the first apparent manifestation of HIV infection in Malawi.

Spitzer MS, Batumba NH, Chirambo T, Bartz-Schmidt KU, Kayange P, Kalua K, Szurman P. Spitzer MS, et al. Clin Exp Ophthalmol. 2008 Jul;36(5):422-5. Clin Exp Ophthalmol. 2008. PMID: 18939345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

547 results

Search Page

Filters